Abstract
Objective: To identify discrete clusters comprising clinical features and inflammatory biomarkers in children with JIA and to determine cluster alignment with JIA categories. Methods: A Canadian prospective inception cohort comprising 150 children with JIA was evaluated at baseline (visit 1) and after six months (visit 2). Data included clinical manifestations and inflammation-related biomarkers. Probabilistic principal component analysis identified sets of composite variables, or principal components, from 191 original variables. To discern new clinical-biomarker clusters (clusters), Gaussian mixture models were fit to the data. Newly-defined clusters and JIA categories were compared. Agreement between the two was assessed using Kruskal-Wallis analyses and contingency plots. Results: Three principal components recovered 35% (three clusters) and 40% (five clusters) of the variance in patient profiles in visits 1 and 2, respectively. None of the clusters aligned precisely with any of the seven JIA categories but rather spanned multiple categories. Results demonstrated that the newly defined clinical-biomarker lustres are more homogeneous than JIA categories. Conclusion: Applying unsupervised data mining to clinical and inflammatory biomarker data discerns discrete clusters that intersect multiple JIA categories. Results suggest that certain groups of patients within different JIA categories are more aligned pathobiologically than their separate clinical categorizations suggest. Applying data mining analyses to complex datasets can generate insights into JIA pathogenesis and could contribute to biologically based refinements in JIA classification.
Original language | English |
---|---|
Pages (from-to) | 1066-1075 |
Number of pages | 10 |
Journal | Rheumatology |
Volume | 59 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 1 2020 |
Externally published | Yes |
Bibliographical note
Funding Information:Funding: This work was supported by the Canadian Institutes for Health Research, Institutes of Musculoskeletal Health and Arthritis and Infection and Immunity (Funding Reference Number 82517); The Arthritis Society (Funding Reference Number 82517); The Canadian Arthritis Network (Grant Number SRI-IJD-01); The University of Saskatchewan; The Manitoba Institute of Child Health, McGill University (Division of Pediatric Rheumatology); Memorial University; The University of British Columbia (Division of Pediatric Rheumatology); and Clinical Research Centre of the Centre Hospitalier Universitaire de Sherbrooke.
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
ASJC Scopus Subject Areas
- Rheumatology
- Pharmacology (medical)